Abbott Laboratories (ABT) Construction in Progress (2009 - 2025)
Abbott Laboratories (ABT) posted Construction in Progress of $2.6 billion for Q4 2025, up 3.18% sequentially from $2.5 billion in Q4 2024, and up 3.18% YoY from $2.5 billion in Q4 2024.
Abbott Laboratories (ABT) Construction in Progress (2009 - 2025) Analysis & Trends
Abbott Laboratories has reported Construction in Progress for 17 years, with the latest figure at $2.6 billion in Q4 2025.
- Quarterly Construction in Progress rose 3.18% year-over-year to $2.6 billion in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $2.6 billion (up 3.18% YoY) and the FY2025 annual result came in at $2.6 billion, up 3.18% from the prior year.
- Construction in Progress grew to $2.6 billion in Q4 2025 per ABT's latest filing, from $2.5 billion in the prior quarter.
- Over five years, Construction in Progress peaked at $2.6 billion in Q4 2025 and troughed at $1.3 billion in Q4 2021.
- A 5-year average of $2.0 billion and a median of $2.1 billion in 2023 frame the typical range for Construction in Progress.
- The sharpest annual moves came in 2021 and 2023: Construction in Progress slipped 3.91% in 2021, then surged 39.08% in 2023.
- Over 5 years, Construction in Progress stood at $1.3 billion in 2021, then climbed by 13.8% to $1.5 billion in 2022, then soared by 39.08% to $2.1 billion in 2023, then grew by 20.54% to $2.5 billion in 2024, then grew by 3.18% to $2.6 billion in 2025.
- According to Business Quant data, Construction in Progress over the past three periods registered $2.6 billion, $2.5 billion, and $2.1 billion for Q4 2025, Q4 2024, and Q4 2023 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Construction in Progress (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 200.19 Bn | 194.59 Bn | 7.27 Bn | - |
| 2 | Stryker | 129.95 Bn | 126.47 Bn | 4.50 Bn | - |
| 3 | Medtronic | 120.06 Bn | 110.84 Bn | 6.41 Bn | - |
| 4 | Boston Scientific | 74.14 Bn | 73.60 Bn | 3.85 Bn | 911.00 Mn |
| 5 | Edwards Lifesciences | 52.74 Bn | 48.49 Bn | 1.35 Bn | - |
| 6 | Dexcom | 34.60 Bn | 32.65 Bn | 830.00 Mn | - |
| 7 | GE HealthCare Technologies | 34.20 Bn | 32.10 Bn | 2.18 Bn | - |
| 8 | Koninklijke Philips | 26.46 Bn | 23.13 Bn | 4.55 Bn | - |
| 9 | Steris | 23.25 Bn | 22.77 Bn | 684.20 Mn | 455.10 Mn |
| 10 | Zimmer Biomet Holdings | 19.36 Bn | 18.95 Bn | 1.54 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 2.57 Bn |
| Dec 31, 2024 | 2.49 Bn |
| Dec 31, 2023 | 2.06 Bn |
| Dec 31, 2022 | 1.48 Bn |
| Dec 31, 2021 | 1.30 Bn |
| Dec 31, 2020 | 1.36 Bn |
| Dec 31, 2019 | 1.11 Bn |
| Dec 31, 2018 | 894.00 Mn |
| Dec 31, 2017 | 732.00 Mn |
| Dec 31, 2016 | 962.00 Mn |
| Dec 31, 2015 | 928.00 Mn |
| Dec 31, 2014 | 727.00 Mn |
| Dec 31, 2013 | 868.00 Mn |
| Dec 31, 2012 | 954.00 Mn |
| Dec 31, 2011 | 698.87 Mn |
| Dec 31, 2010 | 577.46 Mn |
| Dec 31, 2009 | 604.81 Mn |